Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ivermectin in Treatment of Mild to Moderate COVID-19 Infection: a Randomized ,Double Blind,Placebo,Controlled Trial

NCT05076253 is registered in ClinicalTrials.gov with Bangkok Metropolitan Administration Medical College and Vajira Hospital as lead sponsor.

NCT NCT05076253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05076253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ivermectin in Treatment of Mild to Moderate COVID-19 Infection: a Randomized ,Double Blind,Placebo,Controlled Trial
Lead sponsor
Bangkok Metropolitan Administration Medical College and Vajira Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
September 1, 2021
Completion date
December 1, 2021
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug, ivermectin poisoning, safety, sars-cov2 infection